Sun, Dec 28, 2014, 5:27 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Aethlon Medical, Inc. Message Board

  • biotechaab biotechaab Jan 14, 2013 12:58 PM Flag

    (NRIFF) Price: 0.065 // 3 Approved drugs + FDA decision on March 4 = 500%++ Potential

     

    You can buy this undiscovered Goldmine currently at almost all time low .GLTA

    FDA approval for the "Best in Class topical medication" on March 4 ,2013 . Nuvo has already a great Partnership with Big Player Covidien in place .

    Nuvo will hit profitability this year with 2 new product launches in 2Q 2013 .

    Upcoming Milestones 2013 :

    March 4, 2013 PDUFA date for Pennsaid 2%

    Q2 2013 worldwide launch of Pliaglis by Galderma

    .....

    Nuvo Research (NRI.TO) or (NRIFF)

    Market Cap : $ 36 M
    Cash: $ 12 M
    Price 0.065 $

     Growing revenue with 3 approved pain products:

     Pennsaid®: topical NSAID for osteoarthritis, partnered with Covidien for
    U.S., targeting $8B oral NSAID market

     Pliaglis®: analgesic peelable cream, targeting global cosmetic and
    dermatology markets, partnered with Galderma, worldwide launch
    commencing Q2 2013

    ..............................

    This topic is deleted.
 
AEMD
0.285+0.009(+3.26%)Dec 26 3:52 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
PG&E Corporation
NYSEFri, Dec 26, 2014 4:02 PM EST
Fluor Corporation
NYSEFri, Dec 26, 2014 4:03 PM EST